ADMA financials
ADMA Biologics (ADMA) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
ADMA income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $510.17M | $292.76M | $191.44M | $146.93M | 0.60 |
| 2024 | $426.45M | $219.55M | $138.98M | $197.67M | 0.81 |
| 2023 | $258.21M | $88.94M | $21.63M | -$28.24M | -0.13 |
| 2022 | $154.08M | $35.27M | -$39.37M | -$65.90M | -0.43 |
| 2021 | $80.94M | $1.17M | -$58.37M | -$71.65M | -0.61 |
| 2020 | $42.22M | -$19.07M | -$64.91M | -$75.75M | -1.02 |
- ADMA revenue was $510.17M in fiscal 2025, net income $146.93M.
Updated 2026-11-02 23:12 UTC